Skip to main content
. 2015 Apr 22;3:65–74. doi: 10.1016/j.ymgmr.2015.03.011

Fig. 1.

Fig. 1

Results of treatment with idursulfase in 17 MPS II patients. In the right upper corner of some figures the p-value is given. 1a shows the decrease of urinary glycosaminoglycans from baseline during ERT; 1b: individual ratio to normal of splenomegaly at baseline and at 2, 5–6 and 7–8 years of ERT are reported: after 5 years of treatment no patient has splenomegaly; and 1c: hepatomegaly decreased over time: only very mild hepatomegaly was found at 7–8 years of ERT.